CAREY STEPHEN P. 4

What Happened
Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals (ANIP), sold 2,850 shares in an open-market transaction on June 29, 2026. The shares were sold at a weighted average price of $84.12, producing gross proceeds of $239,742. This was a sale (disposition), not a purchase.

Key Details

• Transaction date: 2026-06-29; Form 4 filed: 2026-06-30 (timely filing).
• Prices: multiple trades at $83.39–$84.63; weighted average reported $84.12.
• Shares sold: 2,850; total proceeds: $239,742.
• Footnotes: Sale executed pursuant to a Rule 10b5-1 trading plan adopted March 6, 2026; multiple trades produced the price range and weighted average.
• Shares owned after transaction: not specified in the provided extract — see the full Form 4 for post-transaction holdings.

Context
Sales by executives can be routine (e.g., pre-planned trading plans, diversification, or tax needs). The 10b5-1 plan noted here indicates the trades were pre-scheduled, which typically limits the ability to infer sentiment from the sale alone. For investors, purchases usually carry clearer bullish signals; recorded sales like this are factual disclosures of insider activity.